Penumbra Inc (PEN) Stock Analysis

    $PEN · HEALTHCARE · MEDICAL DEVICES

    Penumbra (PEN), a MEDICAL DEVICES company, has a market capitalization of about $12.59B and trades at 79.3x trailing earnings.

    Price

    $319.55

    Market cap

    $12.59B

    P/E ratio

    79.3x

    Dividend yield

    —

    About Penumbra Inc

    Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States, Europe, Canada, Australia, and internationally. The company is headquartered in Alameda, California.

    How StockWorthy values PEN

    StockWorthy forecasts Penumbra Inc's revenue, operating profitability, reinvestment (capital expenditure, depreciation and working capital) and unlevered free cash flow, then discounts those cash flows using a normalized cost of capital built from PEN's size, profitability and balance-sheet risk. Terminal growth is adjusted to reflect the company's mature growth profile rather than a fixed number. The model presents bear, base and bull scenarios, and every key assumption stays transparent and adjustable in the full StockWorthy analysis. Results are educational and not investment advice.

    Related stocks

    Medtronic PLC$MDTBoston Scientific Corp$BSXGE HealthCare Technologies Inc.$GEHCInsulet Corporation$PODD

    See PEN's Fair Value

    Create a free account to view Penumbra Inc's base-case fair value, the bear–bull modeled range, and every assumption behind them. Free accounts include 5 stock valuations per month — plus Advanced DCF models, financial charts, dividends, and peer analysis.

    Create Free AccountSign In